Literature DB >> 33643912

Computer Tomography Radiomics-Based Nomogram in the Survival Prediction for Brain Metastases From Non-Small Cell Lung Cancer Underwent Whole Brain Radiotherapy.

Ji Zhang1, Juebin Jin1, Yao Ai1, Kecheng Zhu1, Chengjian Xiao1, Congying Xie1,2, Xiance Jin1.   

Abstract

Prognostic parameters and models were believed to be helpful in improving the treatment outcome for patients with brain metastasis (BM). The purpose of this study was to investigate the feasibility of computer tomography (CT) radiomics based nomogram to predict the survival of patients with BM from non-small cell lung cancer (NSCLC) treated with whole brain radiotherapy (WBRT). A total of 195 patients with BM from NSCLC who underwent WBRT from January 2012 to December 2016 were retrospectively reviewed. Radiomics features were extracted and selected from pretherapeutic CT images with least absolute shrinkage and selection operator (LASSO) regression. A nomogram was developed and evaluated by integrating radiomics features and clinical factors to predict the survival of individual patient. Five radiomics features were screened out from 105 radiomics features according to the LASSO Cox regression. According to the optimal cutoff value of radiomics score (Rad-score), patients were stratified into low-risk (Rad-score <= -0.14) and high-risk (Rad-score > -0.14) groups. Multivariable analysis indicated that sex, karnofsky performance score (KPS) and Rad-score were independent predictors for overall survival (OS). The concordance index (C-index) of the nomogram in the training cohort and validation cohort was 0.726 and 0.660, respectively. An area under curve (AUC) of 0.786 and 0.788 was achieved for the short-term and long-term survival prediction, respectively. In conclusion, the nomogram based on radiomics features from CT images and clinical factors was feasible to predict the OS of BM patients from NSCLC who underwent WBRT.
Copyright © 2021 Zhang, Jin, Ai, Zhu, Xiao, Xie and Jin.

Entities:  

Keywords:  brain metastasis; nomogram; non-small cell lung cancer; overall survival; radiomics; whole brain radiotherapy

Year:  2021        PMID: 33643912      PMCID: PMC7905101          DOI: 10.3389/fonc.2020.610691

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  35 in total

Review 1.  Brain metastases: epidemiology.

Authors:  Quinn T Ostrom; Christina Huang Wright; Jill S Barnholtz-Sloan
Journal:  Handb Clin Neurol       Date:  2018

2.  Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery.

Authors:  Chih-Ying Huang; Cheng-Chia Lee; Huai-Che Yang; Chung-Jung Lin; Hsiu-Mei Wu; Wen-Yuh Chung; Cheng-Ying Shiau; Wan-Yuo Guo; David Hung-Chi Pan; Syu-Jyun Peng
Journal:  J Neurooncol       Date:  2020-02-04       Impact factor: 4.130

Review 3.  Treatment of brain metastases from lung cancer: chemotherapy.

Authors:  Wolfgang Schuette
Journal:  Lung Cancer       Date:  2004-08       Impact factor: 5.705

4.  Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).

Authors:  Gerard A Silvestri; Michael K Gould; Mitchell L Margolis; Lynn T Tanoue; Douglas McCrory; Eric Toloza; Frank Detterbeck
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

5.  Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.

Authors:  Yun Oh; Sarah Taylor; Benjamin Nebiyou Bekele; J Matthew Debnam; Pamela K Allen; Dima Suki; Raymond Sawaya; Ritsuko Komaki; David J Stewart; Daniel D Karp
Journal:  Cancer       Date:  2009-07-01       Impact factor: 6.860

6.  Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.

Authors:  Paul W Sperduto; Samuel T Chao; Penny K Sneed; Xianghua Luo; John Suh; David Roberge; Amit Bhatt; Ashley W Jensen; Paul D Brown; Helen Shih; John Kirkpatrick; Amanda Schwer; Laurie E Gaspar; John B Fiveash; Veronica Chiang; Jonathan Knisely; Christina Maria Sperduto; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-26       Impact factor: 7.038

7.  Brain metastasis. Prognostic value of the number of involved extracranial organs.

Authors:  D Rades; L Gerdan; B Segedin; V Nagy; M T Khoa; N T Trang; S E Schild
Journal:  Strahlenther Onkol       Date:  2013-10-10       Impact factor: 3.621

8.  Utility of graded prognostic assessment in evaluation of patients with brainstem metastases treated with radiosurgery.

Authors:  Rudra Joshi; Matthew D Johnson; Ann Maitz; Kimberly S Marvin; Rick E Olson; Inga S Grills
Journal:  Clin Neurol Neurosurg       Date:  2016-05-18       Impact factor: 1.876

9.  Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with whole-brain radiotherapy: a multicenter retrospective study.

Authors:  Younghee Park; Kyung Su Kim; Kyubo Kim; Eui Kyu Chie; Jin Ho Kim; Jae-Sung Kim; Tae Hyun Kim; Dae Yong Kim; Won Il Jang; Mi-Sook Kim; Tae Ryool Koo; Ah Ram Chang
Journal:  J Neurooncol       Date:  2015-09-05       Impact factor: 4.130

Review 10.  Translational implications of tumor heterogeneity.

Authors:  Mariam Jamal-Hanjani; Sergio A Quezada; James Larkin; Charles Swanton
Journal:  Clin Cancer Res       Date:  2015-03-15       Impact factor: 12.531

View more
  3 in total

1.  The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study.

Authors:  Yixin Wang; Jinwei Lang; Joey Zhaoyu Zuo; Yaqin Dong; Zongtao Hu; Xiuli Xu; Yongkang Zhang; Qinjie Wang; Lizhuang Yang; Stephen T C Wong; Hongzhi Wang; Hai Li
Journal:  Eur Radiol       Date:  2022-06-09       Impact factor: 5.315

2.  A nomogram model for predicting prognosis of obstructive colorectal cancer.

Authors:  Jian Lv; Yuan Yuan Liu; Yi Tao Jia; Jing Li He; Guang Yao Dai; Peng Guo; Zhao Long Zhao; Yan Ni Zhang; Zhong Xin Li
Journal:  World J Surg Oncol       Date:  2021-12-02       Impact factor: 2.754

3.  Development and validation a radiomics nomogram for diagnosing occult brain metastases in patients with stage IV lung adenocarcinoma.

Authors:  Ping Cong; Qingtao Qiu; Xingchao Li; Qian Sun; Xiaoming Yu; Yong Yin
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.